Association of the TSHR gene with Graves' disease: The first disease specific locus

European Journal of Human Genetics

Volumn 13, Issue 11, 2005, Pages 1223-1230

  Dechairo, Bryan M ^a   Zabaneh, Delilah ^a   Collins, Joanne ^b   Brand, Oliver ^b   Dawson, Gary J ^a   Green, Angie P ^a   Mackay, Ian ^a   Franklyn, Jayne A ^b   Connell, John M ^c   Wass, John A H ^d   Wiersinga, Wilmar M ^e   Hegedus, Laszlo ^f   Brix, Thomas ^f   Robinson, Bruce G ^g   Hunt, Penny J ^h   Weetman, Anthony P ⁱ   Carey, Alisoun H ^a   Gough, Stephen C ^b  

^a Oxagen Ltd   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c WESTERN INFIRMARY   (United Kingdom)

^d NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

^g UNIVERSITY OF SYDNEY   (Australia)

^h CHRISTCHURCH HOSPITAL   (New Zealand)

ⁱ UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

AITD; GD; Genetic; Graves; htSNP; TSHR

Indexed keywords

THYROTROPIN RECEPTOR;

ARTICLE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GRAVES DISEASE; HAPLOTYPE; HASHIMOTO DISEASE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; UNITED KINGDOM; CASE CONTROL STUDY; CHROMOSOME MAP; GENETICS; POPULATION GENETICS; VALIDATION STUDY;

CASE-CONTROL STUDIES; CHROMOSOME MAPPING; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETICS, POPULATION; GRAVES DISEASE; GREAT BRITAIN; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, THYROTROPIN;

EID: 33644790167     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201485     Document Type: Article

References (31)

1. Tunbridge WM, Evered DC, Hall R et al: The spectrum of thyroid disease in a community: The Whickham survey. Clin Endocrinol (Oxford) 1977; 7: 481-493.
2. Weetman AP: Graves' disease. N Engl J Med 2000; 343: 1236-1248.
3. Tunbridge WM, Brewis M, French JM et al: Natural history of autoimmune thyroiditis. BMJ 1981; 282: 258-262.
4. Brix TH, Kyvik KO, Hegedus L: A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab 2000; 85: 536-539.
5. Brix TH, Kyvik KO, Christensen K, Hegedus L: Evidence for a major role of heredity in Graves' disease: A population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 2001; 86: 930-934.
6. Sakai K, Shirasawa S, Ishikawa N et al: Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum Mol Genet 2001; 10: 1379-1386.
7. Tomer Y, Ban Y, Concepcion E et al: Common and unique susceptibility loci in Graves and Hashimoto diseases: Results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 2003; 73: 736-747.
8. Simmonds MJ, Howson JM, Heward JM et al: Regression mapping of association between the human leukocyte antigen region and Graves disease. Am J Hum Genet 2005; 76: 157-163.
9. Ueda H, Howson JM, Esposito L et al: Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-511.
10. Smyth D, Cooper JD, Collins JE et al: Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 2004; 53: 3020-3023.
11. Velaga MR, Wilson V, Jennings CE et al: The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 2004; 89: 5862-5865.
12. de Roux N, Shields DC, Misrahi M et al: Analysis of the thyrotropin receptor as a candidate gene in familial Graves' disease. J Clin Endocrinol Metab 1996; 81: 3483-3486.
13. Allahabadia A, Heward JM, Mijovic C et al: Lack of association between polymorphism of the thyrotropin receptor gene and Graves' disease in United Kingdom and Hong Kong Chinese patients: Case control and family-based studies. Thyroid 1998; 8: 777-780.
14. Ban Y, Greenberg DA, Concepcion ES, Tomer Y: A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves' disease. Thyroid 2002; 12: 1079-1083.
15. Chistyakov DA, Savost'anov KV, Turakulov RI et al: Complex association analysis of graves disease using a set of polymorphic markers. Mol Genet Metab 2000; 70: 214-218.
16. Cuddihy RM, Dutton CM, Bahn RS: A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females. Thyroid 1995; 5: 89-95.
17. Ho SC, Goh SS, Khoo DH: Association of Graves' disease with intragenic polymorphism of the thyrotropin receptor gene in a cohort of Singapore patients of multi-ethnic origins. Thyroid 2003; 13: 523-528.
18. Kaczur V, Takacs M, Szalai C et al: Analysis of the genetic variability of the 1st (CCC/ACC, P52T) and the 10th exons (bp 1012-1704) of the TSH receptor gene in Graves' disease. Eur J Immunogenet 2000; 27: 17-23.
19. Kotsa KD, Watson PF, Weetman AP: No association between a thyrotropin receptor gene polymorphism and Graves' disease in the female population. Thyroid 1997; 7: 31-33.
20. Sale MM, Akamizu T, Howard TD et al: Association of autoimmune thyroid disease with a microsatellite marker for the thyrotropin receptor gene and CTLA-4 in a Japanese population. Proc Assoc Am Physicians 1997; 109: 453-461.
21. Simanainen J, Kinch A, Westermark K et al: Analysis of mutations in exon 1 of the human thyrotropin receptor gene: High frequency of the D36H and P52T polymorphic variants. Thyroid 1999; 9: 7-11.
22. Daly MJ, Rioux JD, Schaffner SF et al: High-resolution haplotype structure in the human genome. Nat Genet 2001; 29: 229-232.
23. Johnson GC, Esposito L, Barratt BJ et al: Haplotype tagging for the identification of common disease genes. Nat Genet 2001; 29: 233-237.
24. Collins JE, Heward JM, Howson JM et al: Common allelic variants of exons 10, 12, and 33 of the thyroglobulin gene are not associated with autoimmune thyroid disease in the United Kingdom. J Clin Endocrinol Metab 2004; 89: 6336-6339.
25. Heward JM, Allahabadia A, Daykin J et al: Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: Replication using a population case control and family-based study. J Clin Endocrinol Metab 1998; 83: 3394-3397.
26. Excoffier L, Slatkin M: Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995; 12: 921-927.
27. Abecasis GR, Cookson WO: GOLD - graphical overview of linkage disequilibrium. Bioinformatics 2000; 16: 182-183.
28. Clayton DG: Population association; in Balding DJ, Bishop M, Cannings C (eds): Handbook o f Statistical Genetics. Chichester: Wiley, 2003, 2nd edn, pp 939-960.
29. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG: Replication validity of genetic association studies. Nat Genet 2001; 29: 306-309.
30. Lohmueller KE, Pearce CL, Pike M et al: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33: 177-182.
31. Kopp P: The TSH receptor and its role in thyroid disease. Cell Mol Life Sci 2001; 58: 1301-1322.